Recent Ozempic Deaths Show Increased Risk of Gastrointestinal Diseases
Ozepmic popularity has skyrocketed over the past few years. The FDA approved the injectable drug in 2017 to help patients manage type 2 diabetes. Along with lowering blood sugar levels, the drug is also an appetite suppressant. Many patients report significant weight loss while taking Ozempic.
Read More
By: admin
Dec 11